Albion Financial Group /Ut

Source: SEC Form 13F · as of Mar 2026

Albion Financial Group /Ut holds 50 biotech & pharma companies tracked by BioSniper, totaling $24.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

50

Total value held

$24.9M

CompanySharesValue
AMGNAMGEN INC24,096$8.5M
ABBVAbbVie Inc.18,800$4.1M
MRKMerck & Co., Inc.30,305$3.6M
JNJJOHNSON & JOHNSON10,439$2.6M
ABTABBOTT LABORATORIES14,992$1.5M
LLYELI LILLY & Co1,142$1.1M
PMPhilip Morris International Inc6,339$1.0M
GEHCGE HealthCare Technologies Inc.13,604$968K
KRMDKORU Medical Systems Inc. Common Stock (DE)216,374$935K
PFEPFIZER INC7,059$198K
GILDGILEAD SCIENCES, INC.577$80K
GENBGenerate Biomedicines Inc.4,854$61K
BMYBRISTOL MYERS SQUIBB CO800$49K
NVSNovartis AG281$43K
AZNASTRAZENECA PLC181$36K
ZTSZoetis Inc.258$30K
ELVElevance Health Inc.56$16K
IDXXIDEXX LABORATORIES INC /DE26$15K
NVONovo Nordisk A/S383$14K
MCKMcKesson Corporation15$13K
CAICaris Life Sciences Inc.678$12K
CORCencora Inc.38$12K
ZBHZimmer Biomet Holdings Inc.90$8K
UNHUnitedHealth Group Incorporated Common Stock (DE)28$8K
VTRSViatris Inc414$6K
CAHCardinal Health Inc.24$5K
LCTXLineage Cell Therapeutics, Inc.3,043$5K
DGXQuest Diagnostics Incorporated11$2K
INSMINSMED Inc13$2K
GMOptec International, Inc.27$2K
HALOHALOZYME THERAPEUTICS, INC.26$2K
RXRXRECURSION PHARMACEUTICALS, INC.520$2K
PRTAPROTHENA CORP PUBLIC LTD CO125$1K
SNYSanofi23$1K
BIIBBIOGEN INC.6$1K
TECHBIO-TECHNE Corp18$941
OGNOrganon & Co.100$599
PRGOPERRIGO Co plc42$452
ELANElanco Animal Health Inc17$407
BAXBaxter International Inc.18$303
ONCBeOne Medicines Ltd.1$297
FATEFATE THERAPEUTICS INC225$270
VIVSVivoSim Labs, INC.159$228
TLRYTilray Brands, Inc.30$195
IMDXInsight Molecular Diagnostics Inc.7$23
SERSerina Therapeutics, Inc.8$16
INOINOVIO PHARMACEUTICALS, INC.5$9
ACBAURORA CANNABIS INC2$7
SNGXSOLIGENIX, INC.1$2
BIVIBIOVIE INC.1$2

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Albion Financial Group /Ut — Biotech 13F Holdings & Portfolio | BioSniper